The Duke Ophthalmology Neuro-Ophthalmology Division has a long-standing tradition of excellence in basic science, translational, and clinical research. Results from basic science and epidemiological studies are translated into well-designed clinical trials, ultimately leading to the development of new therapies for various neuro-ophthalmic disorders such as optic neuropathies, cranial nerve palsies, nystagmus and others.
Duke Neuro-ophthalmology faculty lead and collaborate with other physician-scientists nationwide in many of the clinical trials that define the evidence base for practice.
Research Highlights
- The Duke neuro-ophthalmology division has been involved in cutting edge clinical trials:
- Idiopathic intracranial hypertension treatment trial,
- Quark siRNA intravitreal non-arteritic anterior ischemic optic neuropathy trial
- Pediatric optic pathway glioma trial
- Pediatric optic neuritis treatment trial
Research Interests
- Undiagnosed disease network
- Optic nerve and retinal imaging in optic neuropathies
- Giant cell arteritis
- Leber hereditary optic neuropathy
- Ocular motility abnormalities